AC
IDXX icon

Avestar Capital’s Idexx Laboratories IDXX Stock Holding History

Avestar Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
785
+49
+7% +$27.5K 0.02% 415
2026
Q1 		$414K Sell
736
-4
-0.5% -$2.56K 0.03% 393
2025
Q4 		$501K Sell
740
-179
-19% -$122K 0.03% 337
2025
Q3 		$587K Buy
919
+280
+44% +$170K 0.04% 309
2025
Q2 		$343K Sell
639
-59
-8% -$28.2K 0.02% 369
2025
Q1 		$293K Sell
698
-106
-13% -$46K 0.03% 383
2024
Q4 		$332K Buy
804
+45
+6% +$19.7K 0.03% 363
2024
Q3 		$383K Buy
759
+60
+9% +$29.1K 0.04% 295
2024
Q2 		$341K Buy
699
+137
+24% +$68.8K 0.04% 312
2024
Q1 		$303K Buy
562
+111
+25% +$60.7K 0.03% 336
2023
Q4 		$250K Buy
+451
New +$212K 0.03% 324
2019
Q3 		– Sell
-18
Closed -$3K – 479
2019
Q2 		$3K Hold
18
– – ﹤0.01% 636
2019
Q1 		$2K Hold
18
– – ﹤0.01% 662
2018
Q4 		$2K Buy
18
+10
+125% +$2.05K ﹤0.01% 632
2018
Q3 		$1K Hold
8
– – ﹤0.01% 716
2018
Q2 		$1K Hold
8
– – ﹤0.01% 769
2018
Q1 		$1K Buy
+8
New +$1.48K ﹤0.01% 726

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Avestar Capital's IDXX Position: Q2 2026 in Review

Avestar Capital increased its Idexx Laboratories (IDXX) stake by 6.7% in Q2 2026, buying an estimated $27.5K and bringing the position to 785 shares worth $413K. The position accounts for 0.02% of the portfolio, ranked #415.

Avestar Capital first reported a position in IDXX in Q1 2018 and has held it in 17 quarters since. The position peaked at $587K in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Avestar Capital held 785 shares of Idexx Laboratories worth $413K as of Q2 2026.
  • Avestar Capital bought 49 Idexx Laboratories shares in Q2 2026, an estimated $27.5K.
  • Idexx Laboratories made up 0.02% of Avestar Capital's portfolio in Q2 2026, its #415 holding.
  • Avestar Capital first reported a position in Idexx Laboratories in Q1 2018 and has held it in 17 quarters since.
  • Avestar Capital's Idexx Laboratories position peaked at $587K in Q3 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.